-
Clinics looking to increase use of long-acting reversible contraceptive (LARC) methods have tools and evidence to support their actions.
-
When it comes to emergency contraception (EC), does its availability and use impact ongoing contraceptive methods? Initial research from one study indicates that adolescent mothers who are given a supply of EC are no less likely to use condoms and other forms of birth control than teen mothers who are not given EC.
-
Your next patient is a young married woman who is unable to use hormonal birth control and is not interested in using an intrauterine device. Because she wants to have more children, sterilization is not an option at the present time. What contraceptive methods are available to her?
-
It is estimated some 50 million women in the United States are screened on an annual basis with Pap tests. Clinicians now have another tool in their arsenal that will help distinguish women at increased risk of developing cervical cancer from those at very low risk.
-
Since the NuvaRing contraceptive vaginal ring (Organon, West Orange, NJ) entered the U.S. market in mid-2002, new research has been published that underscores its efficacy and acceptability.
-
With fluoroquinolone-resistant gonorrhea becoming more common in the United States, clinicians have looked to two treatment alternatives, cefixime and ceftriaxone, to combat the sexually transmitted disease (STD).
-
New research from the Womens Health Initiative (WHI) indicates that for many postmenopausal women, combined hormone therapy does not have a clinically significant effect on their health-related quality of life.
-
What is your approach when it comes to oral contraceptives and women who smoke? What is your facilitys standard practice for informing patients on Pap test results?
-
While the oral contraceptive (OC) Yasmin has been the focus of interest in the United States for its potential in treating premenstrual syndrome, its safety has been questioned by Dutch medical officials, who are calling for more epidemiological data on the potential risk for venous thrombosis.
-
New research indicates that use of the oral contraceptive (OC) Yasmin decreased the physical and emotional symptoms associated with a womans menstrual cycle.